Page 3 - இயற்கை வைத்திருத்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Seattle DJC com local business news and data - Business
djc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from djc.com Daily Mail and Mail on Sunday newspapers.
Natura &Co reports strong sales growth of 24% and net profit up 200%, continuing to outperform global CFT market in Q4
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.
Yabancı yılın ilk ayında satıcı oldu
borsagundem.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from borsagundem.com Daily Mail and Mail on Sunday newspapers.
Yabancıdan ocakta 444 1 milyon dolarlık net satış
dunya.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dunya.com Daily Mail and Mail on Sunday newspapers.
DGAP-News: Scenic Biotech BV: Scenic Biotech Appoints Dr. Philippe Dro as Independent Chairman
Scenic Biotech BV: Scenic Biotech Appoints Dr. Philippe Dro as Independent Chairman
02.02.2021 / 09:30
PRESS RELEASE
- Dr. Philippe Dro brings entrepreneurial expertise and biotech, medtech and pharma industry experience
- Successful serial entrepreneur with track record of growing companies, notably for Themis and Glycovaxyn
- Joins at a key juncture in Scenic Biotech s strategic growth, building its pipeline of genetic modifier drug candidates
Amsterdam, The Netherlands, 2 February, 2021 - Scenic Biotech BV ( Scenic ), a pioneer in the discovery of genetic modifiers to enable the development of disease modifying therapeutics for rare genetic disorders and other devastating illnesses, today announced that it has appointed Dr. Philippe Dro as its independent Chairman. A highly experienced entrepreneur, he replaces Dr. Ulrich Grau who retires from the Board of Directors.